Xcelerate, Inc. CEO Discusses Using AI to Advance Medical Care in Africa in Interview with SmallCapVoice.com
On March 10, 2022, Xcelerate (OTC Pink: XCRT) CEO Michael O’Shea discussed the company's innovative use of artificial intelligence (AI) to enhance healthcare access in remote areas of Tanzania. The AI-driven software, initially designed for self-driving cars, allows patients to connect with healthcare professionals via mobile devices, improving treatment efficiency. Xcelerate aims to launch a beta site by Q2 2022 and anticipates generating revenue by year-end. Additionally, the company plans to file several patents related to its technology, aiming for an uplisting to OTCQB.
- Plan to launch a beta site for AI-driven healthcare by end of Q2 2022.
- Expected revenue generation before the end of 2022.
- Intention to file multiple patents for innovative medical technology.
- Unique application of AI to improve healthcare access in remote areas.
- None.
AUSTIN, Texas, March 10, 2022 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT), to discuss how the Company is utilizing artificial intelligence (AI) and other technologies to deliver healthcare to remote areas of Africa.
Xcelerate is an innovation and development company that marries non-medical engineering, advancements and systems with MedTech and clinical care within the healthcare industry. Speaking with SCV’s Stuart Smith, O’Shea explains Xcelerate’s plan to use AI to give the people of Tanzania, Africa, greater access to physicians and medical care.
“The software-based system was originally developed by the folks that develop the AI for self-driving cars and we've applied that to a medical use in an essence. This program allows people in remote areas to reach healthcare professionals by the use of any mobile device. It then builds a database on these people. Facial recognition, if they're a returning patient, allows them to input basic triage information and give the physician a head start on being able to treat the patient prescribed medications,” he says. “We expect that we'll have a beta site for the project launched by end of second quarter and expect to be generating revenues before the end of this year. Additionally, we're filing one patent, hopefully in the next week and three others to follow all based on our initial license, but to be used in surgical instruments and retrofitting them to existing surgical, surgical wounds.”
The interview also highlights the unique expertise of the Xcelerate team, along with several corporate milestones that are moving the Company toward uplisting to the OTCQB and reaching other corporate objectives.
The full interview can be viewed at https://www.smallcapvoice.com/interview-xcelerate-xcrt/.
About SmallCapVoice.com
SmallCapVoice.com, Inc. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies, small cap and micro-cap stocks build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, podcasts, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks in which they are interested. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTCMarkets. To learn more about SmallCapVoice.com and its services, please visit https://www.smallcapvoice.com/small-cap-stock-otc-investor-relations-financial-public-relations/.
Socialize with SmallCapVoice and their clients at
Facebook: https://www.facebook.com/SmallCapVoice/
Twitter: https://twitter.com/smallcapvoice
Instagram: https://www.instagram.com/smallcapvoice/
Forward-Looking Statements
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as ''expects,'' ''anticipates,'' ''intends,'' or ''believes.'' Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
Contact Information:
Xcelerate Inc.
www.Xcelerate.Global
854-900-2020
Mike@Xcelerate.Global
SmallCapVoice.com
Stuart T. Smith
512-267-2430
Info@SmallCapVoice.com
Source: SmallCapVoice.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1a48dddc-7d7b-4478-a093-33ef78ed60d4
FAQ
What is Xcelerate's plan for healthcare in Africa?
When does Xcelerate expect to launch its beta site?
What revenue expectations does Xcelerate have for 2022?
How is Xcelerate using AI technology?
What patents does Xcelerate plan to file?
